Elsevier

Maturitas

Volume 2, Issue 2, July 1980, Pages 147-154
Maturitas

Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy

https://doi.org/10.1016/0378-5122(80)90049-3Get rights and content

Abstract

Plasma levels of levonorgestrel and ethinyl oestradiol were estimated in six women who took part in a double blind cross-over trial of hormone replacement therapy. Over a 12 mth period, each woman received each of the following oral drugs for 3 mth: ethinyl oestradiol 50 μg, levonorgestrel 250 μg, combination of ethinyl oestradiol 50 μg and levonorgestrel 250 μg (Nordiol), and placebo. Plasma samples were collected at 2, 8 and 26 h after morning medication each month. Plasma levels of norgestrel were increased when ethinyl oestradiol was added in the form of the combined preparation “Nordiol”. The addition of ethinyl oestradiol to norgestrel therapy also resulted in significant differences between patients in the plasma norgestrel levels. There was approximately a three-fold difference between individuals in the plasma levels of ethinyl oestradiol achieved on the same fixed dose. No simple relationship was evident between plasma levels of norgestrel or ethinyl oestradiol and any of the clinical features measured.

References (15)

There are more references available in the full text version of this article.

Cited by (18)

  • Intrasubject variability in the pharmacokinetics of ethynyloestradiol

    1991, Journal of Steroid Biochemistry and Molecular Biology
  • Pharmacokinetics of gestagens: Some problems

    1990, American Journal of Obstetrics and Gynecology
View all citing articles on Scopus
View full text